Daunorubicin Citrate Liposomal Intraven. - Daunorubicin Citrate Liposome - Injection Generic Drug

General Information

• Below is miscellaneous information regarding Daunorubicin Citrate Liposomal Intraven.
• Daunoxome
• dawn-oh-REWB-eh-sin

Possible Side Effects

• Nausea, diarrhea, headache, constipation, dizziness, fatigue, hair loss, or drowsiness may occur.
• If any of these effects persist or worsen, notify your doctor promptly.
• Tell your doctor immediately if any of these serious side effects occur.

Drug Interactions

• Tell your doctor of all prescription and nonprescription medication you may use, especially.

Overdose

• If overdose is suspected, contact your local poison control center or emergency room immediately.
• Symptoms of overdose may include.

What To Do In Case Of Medical Emergency

• Your condition can cause complications in a medical emergency.
• For enrollment information call MedicAlert at 1-800-854-1166 (USA), or 1-800-668-1507 (Canada).

What To Do In Case Of Missed Dose

• If you miss a dose or if the dose is interrupted, contact your doctor immediately to establish a new dosing schedule.

Medicinal Applications

• This medication is used to treat certain types of cancer (for example, advanced Kaposi's sarcoma).

Read Before Using Daunorubicin Citrate Liposomal Intraven. (precautions)

• Tell your doctor your medical history, especially of.

Daunorubicin Citrate Liposomal Intraven. Miscellaneous Notes

• Laboratory and/or medical tests (including heart function tests) may be performed to monitor for side effects and response to treatment.

Warning

• Daunorubicin may cause heart problems (including heart failure) or bone marrow suppression.
• Notify your doctor immediately if you develop an irregular heartbeat, trouble breathing, swelling of the hands or feet, easy bruising or bleeding, or signs of infection such as fever, unusual fatigue, or persistent sore throat.
• Tell your doctor if you have liver problems, heart problems, or have had chest x-rays.
• You may require smaller doses of daunorubicin or require different treatment.
• Daunorubicin can cause a reaction during the time the drug is being administered.
• Symptoms of this reaction include back pain, flushing, and chest tightness.
• Notify the doctor or nurse immediately if you experience these symptoms.

Daunorubicin Citrate Liposomal Intraven. Storage Instructions

• Store vials in a refrigerator between 36 and 46 degrees F (2 to 8 degrees C) away from light and moisture.
• After mixing and dilution in correct IV fluids (consult your pharmacist for details), the drug is stable at refrigerator temperature for six hours.
• Discard any unused liquid.

Usage Instructions

• Follow all instructions for dilution with correct IV fluids.
• Follow all safety precautions.
• Consult your pharmacist for details.
• Give this medication by injection into a vein (IV), generally over 60 minutes, every two weeks or as directed by the doctor.
• The length of treatment depends on your condition and response to therapy.
• Do not inject this medication into the muscle (IM) or just beneath the skin (subcutaneously).
• Closely monitor for redness, pain and swelling at or around the injection site (see SIDE EFFECTS).
• This medication should be checked visually for particles before use.
• If present, do not use the liquid.